Sign In
By signing in or creating an account, you agree with Associated Broadcasting Company's Terms & Conditions and Privacy Policy.
By signing in or creating an account, you agree with Associated Broadcasting Company's Terms & Conditions and Privacy Policy.
New Delhi: The shares of Colgate-Palmolive India Ltd are expected to be in focus on July 23, 2025, Wednesday a day after the FMCJ major declared its Q1 Results for 2025-26.
In April-June quarter, the FMCG major posted a decline of 11.9 per cent in its net profit at Rs 320.62 crore as against Rs 363.98 crore in the same quarter a year ago.
The dip was recorded as there was a subdued urban demand and elevated competition intensity, the company said on its filing.
In a regulatory filing, Colgate-Palmolive India Ltd (CPIL) said that its sales went down 4.38 per cent to Rs 1.420.64 crore in the quarter ended June 2025. It stood at Rs 1,485.76 crore in the corresponding period a year ago.
“Our Q1 results reflect persistent headwinds from tough operating conditions on account of subdued urban demand and elevated competition intensity. The current quarter performance is also influenced by cycling a high base from the previous year," said CPIL Managing Director & CEO Prabha Narasimhan.
The company’s total expenses in the June quarter dipped 1 per cent to Rs 1,020.05 crore, while the total income, including other income, went down 4.48 per cent in the June quarter to Rs 1,452 crore.
"We continued to work towards execution of our strategic priorities. We have made good strides in category premiumisation, with our premium portfolio delivering strong revenue growth," she said
Narasimhan expected the company to overcome the challenges and anticipate a gradual recovery in the back half of the year.
On 22nd July, the shares of Colgate-Palmolive settled at Rs 2,375.90 on BSE. The stock gave a negative return of around 14 per cent in the last six months and over 24 per cent in the last one year.
(Disclaimer: (Disclaimer: This article is only meant to provide information. TV9 does not recommend buying or selling shares or subscriptions of any IPO, Mutual Funds, gold and crypto assets.))
